FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2536761721> ?p ?o ?g. }

• W2536761721 endingPage "97" @default.
• W2536761721 startingPage "91" @default.
• W2536761721 abstract "HPV attributable cancers are the second most common infection-related cancers worldwide, with much higher burden in less developed regions. There are currently no country-specific estimates of the burden of these cancers in Nigeria just like many other low and middle income countries. In this study, we quantified the proportion of the cancer burden in Nigeria that is attributable to HPV infection from 2012 to 2014 using HPV prevalence estimated from previous studies and data from two population based cancer registries (PBCR) in Nigeria. We considered cancer sites for which there is strong evidence of an association with HPV infection based on the International Agency for Research on Cancer (IARC) classification. We obtained age and sex-specific estimates of incident cancers and using the World Standard Population, we derived age standardized incidence (ASR) rates for each cancer type by categories of sex, and estimated the population attributable fractions (PAF). The two PBCR reported 4336 new cancer cases from 2012 to 2014. Of these, 1627 (37.5%) were in males and 2709 (62.5%) in females. Some 11% (488/4336) of these cancers were HPV associated; 2% (38/1627) in men and 17% (450/2709) in women. Of the HPV associated cancers, 7.8% occurred in men and 92.2% in women. The ASRs for HPV associated cancers was 33.5 per 100,000; 2.3 and 31.2 per 100,000 in men and women respectively. The proportion of all cancers attributable to HPV infection ranged from 10.2 to 10.4% (442–453 of 4336) while the proportion of HPV associated cancers attributable to HPV infection ranged from 90.6% to 92.8% (442–453 of the 488 cases). In men, 55.3% to 68.4% of HPV associated cancers were attributable to HPV infection compared to 93.6% to 94.8% in women. The combined ASR for HPV attributable cancers ranged from 31.0 to 31.7 per 100,000. This was 1.4 to 1.7 per 100,000 in men and 29.6 to 30.0 per 100,000 in women. In women, cervical cancer (n = 392, ASR 28.3 per 100,000) was the commonest HPV attributable cancer, while anal cancer (n = 21, ASR 1.2 per 100,000) was the commonest in men. HPV attributable cancers constitute a substantial cancer burden in Nigerian women, much less so in men. A significant proportion of cancers in Nigerian women would be prevented if strategies such as HPV DNA based screening and HPV vaccination are implemented." @default.
• W2536761721 created "2016-10-28" @default.
• W2536761721 creator A5001116169 @default.
• W2536761721 creator A5007921334 @default.
• W2536761721 creator A5008794707 @default.
• W2536761721 creator A5009450101 @default.
• W2536761721 creator A5030994015 @default.
• W2536761721 creator A5040576433 @default.
• W2536761721 creator A5053948091 @default.
• W2536761721 creator A5054345745 @default.
• W2536761721 creator A5064215217 @default.
• W2536761721 creator A5073415541 @default.
• W2536761721 creator A5084596402 @default.
• W2536761721 date "2016-12-01" @default.
• W2536761721 modified "2023-09-27" @default.
• W2536761721 title "The burden of HPV associated cancers in two regions in Nigeria 2012–2014" @default.
• W2536761721 cites W1485870247 @default.
• W2536761721 cites W1543806678 @default.
• W2536761721 cites W1577087980 @default.
• W2536761721 cites W1586961359 @default.
• W2536761721 cites W1601901085 @default.
• W2536761721 cites W1662070995 @default.
• W2536761721 cites W1677190788 @default.
• W2536761721 cites W1913875977 @default.
• W2536761721 cites W1981989535 @default.
• W2536761721 cites W1987350137 @default.
• W2536761721 cites W1996495040 @default.
• W2536761721 cites W2005777124 @default.
• W2536761721 cites W2006274713 @default.
• W2536761721 cites W2008750108 @default.
• W2536761721 cites W2015535841 @default.
• W2536761721 cites W2018451290 @default.
• W2536761721 cites W2037565741 @default.
• W2536761721 cites W2039745983 @default.
• W2536761721 cites W2041176483 @default.
• W2536761721 cites W2055177313 @default.
• W2536761721 cites W2060929072 @default.
• W2536761721 cites W2067598452 @default.
• W2536761721 cites W2071288591 @default.
• W2536761721 cites W2071848600 @default.
• W2536761721 cites W2072110498 @default.
• W2536761721 cites W2086065739 @default.
• W2536761721 cites W2088084108 @default.
• W2536761721 cites W2098600771 @default.
• W2536761721 cites W2099474359 @default.
• W2536761721 cites W2100655503 @default.
• W2536761721 cites W2106115615 @default.
• W2536761721 cites W2107283868 @default.
• W2536761721 cites W2112995725 @default.
• W2536761721 cites W2115386839 @default.
• W2536761721 cites W2117969937 @default.
• W2536761721 cites W2124942119 @default.
• W2536761721 cites W2137169520 @default.
• W2536761721 cites W2137453447 @default.
• W2536761721 cites W2140481064 @default.
• W2536761721 cites W2142821133 @default.
• W2536761721 cites W2143158562 @default.
• W2536761721 cites W2148341453 @default.
• W2536761721 cites W2148422519 @default.
• W2536761721 cites W2154131697 @default.
• W2536761721 cites W2164710273 @default.
• W2536761721 cites W2165859534 @default.
• W2536761721 cites W2324566364 @default.
• W2536761721 cites W2344234652 @default.
• W2536761721 cites W2394961564 @default.
• W2536761721 cites W2480418585 @default.
• W2536761721 cites W2522693709 @default.
• W2536761721 cites W579072225 @default.
• W2536761721 doi "https://doi.org/10.1016/j.canep.2016.10.008" @default.
• W2536761721 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5124511" @default.
• W2536761721 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27780076" @default.
• W2536761721 hasPublicationYear "2016" @default.
• W2536761721 type Work @default.
• W2536761721 sameAs 2536761721 @default.
• W2536761721 citedByCount "12" @default.
• W2536761721 countsByYear W25367617212019 @default.
• W2536761721 countsByYear W25367617212020 @default.
• W2536761721 countsByYear W25367617212021 @default.
• W2536761721 countsByYear W25367617212022 @default.
• W2536761721 countsByYear W25367617212023 @default.
• W2536761721 crossrefType "journal-article" @default.
• W2536761721 hasAuthorship W2536761721A5001116169 @default.
• W2536761721 hasAuthorship W2536761721A5007921334 @default.
• W2536761721 hasAuthorship W2536761721A5008794707 @default.
• W2536761721 hasAuthorship W2536761721A5009450101 @default.
• W2536761721 hasAuthorship W2536761721A5030994015 @default.
• W2536761721 hasAuthorship W2536761721A5040576433 @default.
• W2536761721 hasAuthorship W2536761721A5053948091 @default.
• W2536761721 hasAuthorship W2536761721A5054345745 @default.
• W2536761721 hasAuthorship W2536761721A5064215217 @default.
• W2536761721 hasAuthorship W2536761721A5073415541 @default.
• W2536761721 hasAuthorship W2536761721A5084596402 @default.
• W2536761721 hasBestOaLocation W25367617212 @default.
• W2536761721 hasConcept C120665830 @default.
• W2536761721 hasConcept C121332964 @default.
• W2536761721 hasConcept C121608353 @default.
• W2536761721 hasConcept C126322002 @default.
• W2536761721 hasConcept C143998085 @default.

• next